JHMI Clinical Guidance for Available Pharmacologic Therapies for COVID-19

June 3, 2020

The Writing Group of the Johns Hopkins University and Johns Hopkins Hospital COVID-19 Treatment Guidance Working Group presents a compressive guidance for existing treatment for COVID-19. The guidance strongly recommends clinical trials for potential treatments before any use, how to use immune modulatory agents to treat COVID-19 such as IL-6R or IL-6 Monoclonal antibodies, intravenous immune globulin (IVIG) and other immunotherapies.